Mqs Management LLC Exelixis, Inc. Transaction History

Mqs Management LLC

  • $177 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
BUY
$20.34 - $23.73 $234,764 - $273,891
11,542 New
11,542 $259,000
Q4 2022

Feb 10, 2023
BUY
$14.96 - $17.39 $84,733 - $98,496
5,664 Added 43.92%
18,561 $297,000
Q3 2022

Nov 09, 2022
BUY
$15.68 - $22.27 $202,224 - $287,216
12,897 New
12,897 $202,000

Others Institutions Holding EXEL

# of Institutions
503
Shares Held
244M
Call Options Held
2.54M
Put Options Held
2.29M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Mqs Management LLC Portfolio

Follow Mqs Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mqs Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mqs Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email